A next-generation cancer vaccine has shown stunning results in mice, preventing up to 88% of aggressive and difficult-to-treat cancers by harnessing dual-pathway nanoparticles that train the immune ...

A new research paper was published in Volume 16 of Oncotarget on October 6, 2025, titled "ACTM-838, a novel systemically delivered bacterial immunotherapy that enriches in solid tumors and delivers IL ...

"ACTM-838 showed durable anti-tumor efficacy in multiple murine tumor models and synergized with anti-PD1 therapy in combination." BUFFALO, NY – October 8, 2025 – A new research paper was published in ...

Children and teenagers are more vulnerable to meningitis than adults because their immune systems are still developing, making it harder for their bodies to fight off infections. Close contact in ...

The super adjuvant vaccine also protected against the spread of cancer to the lungs. When exposed to melanoma cells systemically, which mimics how cancer metastasizes, none of the ...

Researchers provide insights on tuning immunometabolism to resolve inflammation and promote repair at the bone–biomaterial interface ...

ImmunityBio offers significant upside despite ongoing dilution and cash burn concerns. Click here to read an analysis of IBRX stock now.

Provectus Biopharmaceuticals, Inc. (“Provectus” or the “Company”) (OTCQB: PVCT) today announced the publication of independent preclinical research by Aru Narendran, MD, PhD and colleagues at the ...

Fast Track Designation underscores the promise of Werewolf’s INDUKINE™ platformWATERTOWN, Mass., Oct. 08, 2025 (GLOBE NEWSWIRE) -- Werewolf ...

The following is a roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for COVID-19, the illness caused by the virus.

Understanding how interactions between the central nervous system and the immune system contribute to problems of aging, including Alzheimer's ...